Phase III study of T-3262G15% in the pediatric patients with mycoplasma pneumonia
Phase 3
- Conditions
- Mycoplasma pneumonia
- Registration Number
- JPRN-jRCT2080222224
- Lead Sponsor
- Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Age: between 1 and 15 years old
(2) Sex: male or female
(3) Outpatient or inpatient
(4) Presence of symptom/findings of mycoplasma pneumonia
(5) Others
Exclusion Criteria
(1) Medical history of allergy to any quinolone or macrolide antibacterial agents
(2) Pregnant females, being possibly pregnant, or lactating females
(3) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and safety<br>Same as above
- Secondary Outcome Measures
Name Time Method